Stefan H. E. Kaufmann How Can We Improve the Existing Vaccine for Tuberculosis to Combat the Growing Number of Multi-Resistant Strains?
Stefan H. E. Kaufmann Can Biosignatures Be Used to Develop a Reliable, Fast and Low-Cost Test for Tuberculosis?